(Q59689568)
Statements
The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis (English)
0 references
June 1986
0 references
133
0 references
6
0 references
1076-80
0 references